Publications

Luo, Y.*, Xia, Y.*, Liu, D.*, Li, X.*, Li, H.*, Liu, J.*, Zhou, D.*, Dong, Y.*, ... Ma, D.#, Fang, Y.#, Liang, H.# & Gao, Q.#
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
Cell Details

Luo, Y. & Liang, H.
Developmental-status-aware transcriptional decomposition establishes a cell state panorama of human cancers
Genome Medicine Details

Kim, C.*, Wang, X. D.*, Liu, Z., Hao, J., Wang, S., Li, P., ... , Luo, Y., ... & Yu, Y.
Induced degradation of lineage-specific oncoproteins drives the therapeutic vulnerability of small cell lung cancer to PARP inhibitors
Science Advances

2023

Lin, W., Luo, Y., Wu, J., Zhang, H., ... Liang, H.# & Xu, X.#
Loss of ADAR1 in macrophages in combination with interferon-gamma suppresses tumor growth by remodeling the tumor microenvironment
Journal for Immunotherapy of Cancer Details

Shen, X.*, Gao, X.*, Luo, Y.*, Xu, Q., Fan, Y., ... Wu, C.#, Liang, H.# & Wang, L.#
Cxxc finger protein 1 maintains homeostasis and function of intestinal group 3 innate lymphoid cells with aging
Nature Aging Details

Chen, J.*, Liu, K.*, Luo, Y.*, Kang, M., Wang, J., ... Liang, H.#, Wang, L.# & Chen, J.#
Single-cell profiling of tumor immune microenvironment reveals immune irresponsiveness in gastric signet-ring cell carcinoma
Gastroenterology Details

2022

Zhou, Z.*, Chen, M. J. M.*, Luo, Y.*, Mojumdar, K., Kumar, S., ... & Liang, H.
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Cancer Cell Details

Peng, X.*, Luo, Y.*, Li, H., Guo, X., Chen, H., Ji, X. & Liang, H.
RNA editing increases the nucleotide diversity of SARS-CoV-2 in human host cells
PLoS Genetics Details

Luo, Y. & Liang, H.
Convergent usage of amino acids in human cancers as a reversed process of tissue development
Genomics, Proteomics & Bioinformatics Details

Before 2022

Zhao, W.*, Li, J.*, Chen, M. J. M., Luo, Y., Ju, Z., ... Mills, G.# & Liang, H.# (2020)
Large-scale characterization of drug responses of clinically relevant proteins in cancer cell lines
Cancer Cell

Yu, J.*, Navickas, A.*, Asgharian, H.*, Culbertson, B., Fish, L., ... Luo, Y., ... & Goodarzi, H. (2020)
RBMS1 suppresses colon cancer metastasis through targeted stabilization of its mRNA regulon
Cancer Discovery

Hui, Z., Zhou, L., Xue, Z., Zhou, L., Luo, Y., ... & Wang, L. (2018)
Cxxc finger protein 1 positively regulates GM-CSF-derived macrophage phagocytosis through Csf2rα-mediated signaling
Frontiers in Immunology

Luo, Y. & Liang, H. (2023)
Single-cell dissection of tumor microenvironmental response and resistance to cancer therapeutics
Trends in Genetics Details

Luo, Y. & Liang, H. (2023)
Cancer cells employ the most prolific RNA editors: a closer look at the single-cell level  (Research Highlight of Chan et al.)
Cancer Research